Sustained Viral Resilience
Backed by £57m, this programme sits within the Sculpting Innate Immunity opportunity space and seeks to create a new class of medicines that provide durable, broad-spectrum protection against respiratory viruses by engineering the innate immune system.
Funding
There are currently no open funding calls for this programme – sign up to get the latest opportunity space and programme updates.
The projects we have funded were selected from teams and individuals who applied to our previous funding calls for this programme. You can read more about these archived calls below.